Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 11:56AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.62 Insider Own21.06% Shs Outstand45.98M Perf Week-3.03%
Market Cap30.98M Forward P/E- EPS next Y-0.09 Insider Trans0.00% Shs Float19.10M Perf Month-1.54%
Income-18.00M PEG- EPS next Q-0.03 Inst Own59.04% Short Float0.10% Perf Quarter-21.95%
Sales78.10M P/S0.40 EPS this Y91.21% Inst Trans- Short Ratio0.65 Perf Half Y-14.67%
Book/sh-0.54 P/B- EPS next Y-10.00% ROA-23.78% Short Interest0.02M Perf Year-66.32%
Cash/sh1.59 P/C0.81 EPS next 5Y- ROE- 52W Range0.88 - 4.20 Perf YTD-20.99%
Dividend Est.- P/FCF- EPS past 5Y-29.97% ROI-82.72% 52W High-69.52% Beta1.43
Dividend TTM- Quick Ratio1.03 Sales past 5Y13.27% Gross Margin70.40% 52W Low45.45% ATR (14)0.08
Dividend Ex-Date- Current Ratio1.15 EPS Y/Y TTM69.39% Oper. Margin-7.64% RSI (14)48.04 Volatility6.59% 6.50%
Employees114 Debt/Eq- Sales Y/Y TTM-4.06% Profit Margin-23.04% Recom1.40 Target Price4.67
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q77.40% Payout- Rel Volume0.48 Prev Close1.24
Sales Surprise-19.14% EPS Surprise14.89% Sales Q/Q-18.39% EarningsApr 10 BMO Avg Volume30.87K Price1.28
SMA200.06% SMA50-4.68% SMA200-16.41% Trades Volume9,142 Change3.23%
Date Action Analyst Rating Change Price Target Change
Nov-17-22Initiated Cantor Fitzgerald Overweight $9
Jul-29-21Downgrade Canaccord Genuity Buy → Hold $8 → $3
May-23-24 05:00PM
May-09-24 04:30PM
May-02-24 07:30AM
Apr-23-24 12:00PM
Apr-15-24 04:15PM
07:30AM Loading…
Apr-11-24 07:30AM
Apr-10-24 11:52AM
Apr-08-24 04:30PM
Apr-05-24 11:00AM
Apr-03-24 07:30AM
Mar-28-24 07:30AM
Mar-22-24 09:36AM
Mar-21-24 08:00PM
07:30AM Loading…
Feb-29-24 04:34PM
Feb-27-24 07:30AM
Feb-26-24 08:50AM
Feb-21-24 08:45AM
Feb-20-24 07:30AM
Feb-15-24 07:30AM
Feb-06-24 07:30AM
Jan-24-24 07:00AM
Jan-23-24 07:30AM
Jan-02-24 07:30AM
Dec-21-23 04:09PM
Dec-19-23 05:08AM
Dec-13-23 07:30AM
07:30AM Loading…
Nov-24-23 07:30AM
Oct-31-23 12:34PM
Oct-26-23 09:11AM
Oct-25-23 04:13PM
Oct-24-23 07:00AM
Oct-19-23 07:30AM
Oct-16-23 07:30AM
Oct-13-23 07:30AM
Oct-12-23 07:30AM
Oct-04-23 07:30AM
Sep-26-23 07:47AM
Sep-25-23 07:30AM
Sep-20-23 07:00AM
Sep-18-23 04:15PM
Sep-07-23 01:57PM
Sep-05-23 07:00AM
Aug-30-23 10:34AM
Aug-21-23 03:24PM
Aug-05-23 03:30PM
Jul-31-23 07:00AM
Jul-28-23 04:44PM
Jul-21-23 07:00AM
Jul-20-23 07:00AM
Jul-19-23 08:54AM
Jul-12-23 08:13AM
Jun-29-23 07:30AM
Jun-22-23 07:30AM
Jun-12-23 07:30AM
Jun-02-23 12:15PM
May-25-23 05:31PM
May-19-23 05:11PM
May-09-23 12:01PM
May-04-23 07:30AM
Apr-18-23 03:43PM
Apr-12-23 08:36AM
Apr-03-23 07:30AM
Mar-14-23 06:42PM
Mar-07-23 06:00AM
Mar-02-23 05:14AM
Feb-28-23 07:30AM
Feb-22-23 05:30PM
Feb-16-23 07:30AM
Feb-14-23 05:00PM
Jan-04-23 07:45AM
Dec-23-22 10:10AM
Dec-01-22 06:30PM
Nov-17-22 02:09PM
Oct-26-22 07:30AM
Oct-18-22 09:03AM
Oct-13-22 07:30AM
Oct-12-22 07:30AM
Oct-03-22 03:09PM
Sep-26-22 07:30AM
Sep-19-22 04:15PM
Sep-12-22 07:30AM
Aug-02-22 07:30AM
Jul-28-22 11:19AM
Jul-27-22 06:47PM
Jul-16-22 10:33AM
Jul-14-22 12:10PM
Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montreal, Canada.